AVR/NAVR deficiency lowers blood pressure and differentially affects urinary concentrating ability, cognition, and anxiety-like behavior in male and female mice

Physiological Genomics

Volumn 43, Issue 1, 2011, Pages 32-42

  Herrera, Victoria L M ^a   Bagamasbad, Pia ^a   Decano, Julius L ^a   Ruiz Opazo, Nelson ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elevated plus maze; Morris water maze; Signaling proteins; Social transmission of food preference; Water balance

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANXIOLYTIC AGENT; ARGIPRESSIN; ESTROGEN; G PROTEIN COUPLED RECEPTOR; PEPTIDE HORMONE; TESTOSTERONE; VASOPRESSIN RECEPTOR;

ANXIETY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN FUNCTION; C57BL 10 MOUSE; CARDIOVASCULAR FUNCTION; COGNITION; DEMENTIA; DEPHOSPHORYLATION; DEPTH PERCEPTION; FEMALE; GENE LOCUS; HOMEOSTASIS; HYPERTENSION; HYPOTENSION; KIDNEY CONCENTRATING CAPACITY; KIDNEY FUNCTION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATE DEPENDENT LEARNING; UPREGULATION;

ANIMALS; ANXIETY; BLOOD PRESSURE; COGNITION; FEMALE; KIDNEY CONCENTRATING ABILITY; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; RECEPTORS, ANGIOTENSIN; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, VASOPRESSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 78651347631     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00154.2010     Document Type: Article

References (56)

1. Abel P, Nguyen V, Barad M, Deuel TA, Kandel ER, Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88: 615-626, 1997. (Pubitemid 27152404)
2. Alescio-Lautier B, Soumireu-Mourat B. Role of vasopressin in learning and memory in the hippocampus. Prog Brain Res 119: 501-521, 1998. (Pubitemid 29099992)
3. Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: Analysis of published clinical data. J Neuro Sci 203:147-151, 2002. (Pubitemid 35287391)
4. Bouley R, Hasler U, Lu HA, Nunes P, Brown D. Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus. Semin Nephrol 28: 266-278, 2008. (Pubitemid 351756522)
5. Bunsey M, Eichenbaum H. Selective damage to the hippocampal region blocks long-term retention of a natural and nonspatial stimulus-stimulus association. Hippocampus 5: 546-556, 1995. (Pubitemid 26088287)
6. Cechetto DF, Hachinski V, Whitehead SN. Vascular risk factors and Alzheimer's disease. Expert Rev Neurother 8: 743-750, 2008. (Pubitemid 351656825)
7. Coffman TM. A genetic approach for studying the physiology of the type 1A (AT1A) angiotensin receptor. Semin Nephrol 17: 404-411, 1997. (Pubitemid 27398452)
8. Czernik AJ, Pang DT, Greengard P. Amino acid sequences surrounding the cAMP-dependent and calcium/calmodulin-dependent phosphorylation sites in rat and bovine synapsin I. Proc Natl Acad Sci USA 84: 7518-7522, 1987. (Pubitemid 18035718)
9. DeWied D, Diamant M, Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 14: 251-302, 1993. (Pubitemid 23321822)
10. Donaldson ZR, Young LJ. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322: 900-904, 2008.
11. Egashira N, Mishima K, Iwasaki K, Oishi R, Fujiwara M. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions. J Pharm Sci 109: 44-49, 2009.
12. English JD, Sweatt JD. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 272:19103-19106, 1997.
13. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med 264: 224-236, 2008.
14. Gash DM, Boer GJ. Vasopressin: Principles and Properties. New York and London: Plenum, 1987.
15. Gron G, Wunderlich AP, Spitzer M, Tomczak R, Riepe MW. Brain activation during human navigation: gender-different neural networks as substrate of performance. Nat Neurosci 3: 404-408, 2000. (Pubitemid 30185493)
16. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377: 744-747, 1995.
17. Herrera VL, Bagamasbad P, Didishvili T, Decano JL, Ruiz-Opazo N. Overlapping genes in Nalp6/PYPAF5 locus encode two V2-type vasopressin isoreceptors: angiotensin-vasopressin receptor (AVR) and non-AVR. Physiol Genomics 34: 65-77, 2008.
18. Herrera VL, Decano JL, Bagamasbad P, Kufahl T, Steffen M, Ruiz-Opazo N. Sex-specific hippocampus-dependent cognitive deficits and increased neuronal autophagy in DEspR haploinsufficiency in mice. Physiol Genomics 35: 316-329, 2008. (Pubitemid 352790821)
19. Herrera VLM, Tsikoudakis A, Ponce LRB, Matsubara Y, Ruiz-Opazo N. Sex-specific QTLs and interacting-loci underlie salt-sensitive hypertension and target-organ complications in Dahl S/jrHS hypertensive rats. Physiol Genomics 26: 172-179, 2006. (Pubitemid 44246623)
20. Huang Y, Lu W, Ali DW, Pelkey KA, Pitcher GM, Lu YM, Aoto H, Roder JC, Sasaki T, Salter MW, MacDonald JF. CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron 29: 485-496, 2001. (Pubitemid 32206485)
21. Huang YY, Colley PA, Routtenberg A. Postsynaptic then presynaptic protein kinase C activity may be necessary for long-term potentiation. Neuroscience 49: 819-827, 1992.
22. Hurbin A, Orcel H, Ferraz C, Moos FC, Rabie A. Expression of the genes encoding the vasopressin-activated calcium-mobilizing receptor and the dual angiotensin II/vasopressin receptor in the rat central nervous system. J Neuroendocrinol 12: 677-684, 2000. (Pubitemid 30349015)
23. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab 7: 476-484, 2008.
24. Jonasson Z. Meta-analysis of sex differences in rodent models of learning and memory: a review of behavioral and biological data. Neurosci Behav Rev 28: 811-825, 2005. (Pubitemid 40103500)
25. Karl T, Pabst R, von Horsten S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55: 69-83, 2003. (Pubitemid 36975689)
26. Kehoe PG, Wilcock GK. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol 6: 373-378, 2007. (Pubitemid 46389616)
27. Klann E, Antion MD, Banko JL, Hou L. Synaptic plasticity and translation initiation. Learn Memory 11: 365-372, 2004.
28. Korol DL. Role of estrogen in balancing contributions from multiple memory systems. Neurobiol Learn Memory 82: 309-323, 2004.
29. Koshimizu T, Nasa Y, Tanoue A, Oikawa R, Kawahara Y, Kiyono Y, Adachi T, Tanaka T, Kuwaki T, Mori T, Takeo S, Okamura H, Tsujimoto G. V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity. Proc Natl Acad Sci USA 103: 7807-7812, 2006. (Pubitemid 43752862)
30. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405: 955-959, 2000.
31. Liao GY, Wagner DA, Hsu MH, Leonard JP. Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. Mol Pharmacol 59: 960-964, 2001.
32. Lolait SJ, Stewart LQ, Jessop DS, Young WS, O'Carroll AM. The hypothalamic-pituitary axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 148: 849-856, 2007.
33. Lonsdorf EV, Eberly LE, Pusey AE. Sex differences in learning in chimpanzees. Nature 428: 715-716, 2004.
34. Mangrum AJ, Gomez RA, Norwood VF. Effects of AT1A receptor deletion on blood pressure and sodium excretion during altered dietary salt intake. Am J Physiol Renal Physiol 283: F447-F453, 2002.
35. Matsubara M, Kusubata M, Ishiguro K, Uchida T, Titani K, Taniguchi H. Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem 271: 21108-21113, 1996.
36. Mizuno K, Giese KP. Hippocampus-dependent memory formation: do memory type-specific mechanisms exist? J Pharm Sci 98: 191-197, 2005.
37. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297: 681-683, 1982.
38. Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K, Mishina M, Manabe T, Yamamoto T. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem 276: 693-699, 2001.
39. Oghlakian G, Klapholz M. Vasopressin and vasopressin receptor antagonists in heart failure. Cardiol Rev 17: 10-15, 2009.
40. Oh MC, Derkach VA, Guire ES, Soderling TR. Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation. J Biol Chem 281: 752-758, 2006.
41. Patterson C, Feightner JW, Garcia A, Hsiung GYR, MacKnight C, Sadovnick AD. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer's disease. CMJA 178: 548-556, 2008.
42. Phillips MI, de Oliveira EM. Brain renin angiotensin in disease. J Mol Med 86: 715-722, 2008.
43. Prybylowski K, Chang K, Sans N, Kan L, Vicini S, Wenthold RJ. The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47: 845-857, 2005.
44. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4: 487-499, 2005.
45. Rhodes ME, Rubin RT. Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic- pituitary-adrenal axis activity in mammals: a selective review. Brain Res Brain Res Rev 30: 135-152, 1999.
46. Rieff HI, Corfas G. ErbB receptor signaling regulates dendrite formation in mouse cerebellar granule cells in vivo. Eur J Neurosci 23: 2225-2229, 2006.
47. Ruiz-Opazo N, Akimoto K, Herrera VLM. Identification of a novel dual angiotensin II/vasopressin receptor on the basis of molecular recognition theory. Nat Med 1: 1074-1081, 1995.
48. Ruiz-Opazo N, Lopez LV, Herrera VLM. The dual AngII/AVP receptor gene. N119S/C163R variant exhibits sodium-induced dysfunction and cosegregates with salt-sensitive hypertension in the Dahl salt-sensitive hypertensive rat model. Mol Med 8: 24-32, 2002.
49. Ruiz-Opazo N, Tonkiss J. Genome-wide scan for quantitative trait loci influencing spatial navigation and social recognition memory in Dahl rats. Physiol Genomics 26: 145-151, 2006.
50. Shah NM, Pisapia DJ, Maniatis S, Mendelsohn MM, Nemes A, Axel R. Visualizing sexual dimorphism in the brain. Neuron 43: 313-319, 2004.
51. Stoothoff WH, Johnson VW. Tau phosphorylation: physiological and pathological consequences. BB Acta 1739: 280-297, 2005.
52. Strack S, McNeill RB, Colbran RJ. Mechanism and regulation of calcium/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 275: 23798-23806, 2000.
53. Stumpo DJ, Graff JM, Albert KA, Greengard P, Blackshear PJ. Molecular cloning, characterization, and expression of a cDNA encoding the "80- to 87-kDa" myristoylated alanine-rich C kinase substrate: A major cellular substrate for protein kinase C. Proc Natl Acad Sci USA 86: 4012-4016, 1989.
54. Yun J, Schoneberg T, Liu J, Schulz A, Ecelbarger CA, Promeneur D, Nielsen S, Sheng H, Grinberg A, Deng C, Wess J. Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J Clin Invest 106: 1361-1371, 2000.
55. 2+/calmodulin-dependent kinase II. J Neurosci 25: 7697-7707, 2005.
56. Zhang L, Zhao ZX. The impact of synapsins on synaptic plasticity and cognitive behaviors. Neurosci Bull 22: 63-67, 2006.